Pharmaceutical - Mergers & Acquisitions

Filter

Current filters:

Mergers & Acquisitions

Popular Filters

226 to 250 of 641 results

GVK BIO to acquire US CRO Aragen Bioscience

30-01-2014

Asia’s leading small-molecule contract research organization (CRO), GVK BIO, has reached agreement…

Aragen BioscienceBiosimilarsGVK BIOMergers & AcquisitionsPharmaceutical

Medigene acquires Trianta Immunotherapies

27-01-2014

Germany’s Medigene this morning revealed that it has acquired 100% of the shares of the Munich-based…

MedigeneMergers & AcquisitionsOncologyPharmaceuticalTrianta ImmunotherapiesVaccines

McKesson back on track to secure acquisition of Celesio

24-01-2014

US health care services and information technology firm McKesson Corp says that it has reached an agreement…

CelesioMcKessonMergers & AcquisitionsPharmaceutical

Bayer takes advantage of low interest rates, issuing 2 billion euros of bonds

Bayer takes advantage of low interest rates, issuing 2 billion euros of bonds

22-01-2014

German pharma and life sciences group Bayer says it is taking advantage of currently low interest rates…

AlgetaBayerFinancialMergers & AcquisitionsPharmaceutical

NuPathe accepts Teva’s higher counter bid, rejecting Endo offer

21-01-2014

Israel-based Teva Pharmaceutical Industries seems set to bag ownership of US drugmaker NuPathe), which…

Endo Health SolutionsMergers & AcquisitionsNeurologicalNuPathePharmaceuticalTeva Pharmaceutical IndustriesZecuity

Growing Indian pharma market provides incentives for foreign acquisitions

20-01-2014

A recent IMS Institute for Healthcare Informatics global study has revealed that greater access to medicines…

Asia-PacificIndiaMarkets & MarketingMergers & AcquisitionsPharmaceutical

Russian pharma market on verge of further consolidation in 2014

20-01-2014

The Russian pharmaceutical market is on the verge of new deals and acquisitions in 2014, after a record…

Eastern EuropeMergers & AcquisitionsPharmaceuticalRussia

Indian government proceeds with FDI policy, despite warnings

Indian government proceeds with FDI policy, despite warnings

20-01-2014

Overlooking concerns about the scarcity of generic drugs in the domestic market given the spate of multinationals…

Asia-PacificIndiaMergers & AcquisitionsPharmaceuticalPolitics

Johnson & Johnson offered $4.15 billion for its diagnostics unit

Johnson & Johnson offered $4.15 billion for its diagnostics unit

17-01-2014

After days of speculation about divestitures by US health care major Johnson & Johnson, the company last…

Johnson & JohnsonMergers & AcquisitionsPharmaceutical

Moderna spins-out Onkaido Therapeutics to focus on mRNA therapeutics in oncology

15-01-2014

Flush with cash as a result of its mega-million dollar deal with Alexion on the development of drugs…

Mergers & AcquisitionsModerna TherapeuticsOncologyOnkaido TherapeuticsPharmaceuticalResearch

Biotoscana to buy United Medical to create regional specialty pharma group in South America

14-01-2014

Colombia-based Grupo Biotoscana has signed an agreement to acquire Brazilian drugmaker United Medical…

Grupo BiotoscanaMergers & AcquisitionsPharmaceuticalSouth AmericaUnited Medical

McKesson acquisition of German rival Celesio fails

14-01-2014

USA-based health care service and information technology giant McKesson Corp revealed yesterday that…

CelesioMcKessonMergers & AcquisitionsPharmaceutical

Galena Biopharma acquires Mills Pharmaceuticals

14-01-2014

US drugmaker Galena Biopharma revealed that it has acquired Mills Pharmaceuticals, which has the worldwide…

AnagrelideGalena BioPharmaHematologyMergers & AcquisitionsMills PharmaceuticalsPharmaceutical

Big pharma's need to tap M&A for growth will persist in 2014, while dealmaking landscape becomes more competitive, says EY

13-01-2014

Big pharma stayed on the sidelines in the 2013 mergers and acquisitions market despite a continuing need…

GlobalMergers & AcquisitionsPharmaceutical

Pharma M&A deals in 2013 down, but values marginally higher

Pharma M&A deals in 2013 down, but values marginally higher

13-01-2014

Merger and acquisition activity in the pharmaceutical, biotechnology and generic drugs sectors continued…

BiotechnologyGlobalMergers & AcquisitionsPharmaceutical

Akorn gains rights to Betimol from Santen

10-01-2014

US niche generic firm Akorn has acquired the New Drug Application and all rights to Betimol (timolol…

AkornBetimolMergers & AcquisitionsOphthalmicsPharmaceuticalSanten Pharmaceuticals

Endo divests remainder of HealthTronics for up to $130 million

09-01-2014

Endo Health Solutions says it has entered into a definitive agreement to sell its HealthTronics business…

Endo Health SolutionshealthTronicsMergers & AcquisitionsPharmaceutical

NuPathe receives counter offer from Teva topping Endo bid

09-01-2014

US drugmaker NuPathe – currently the subject of a takeover bid from USA-based Endo Health Solutions…

Endo Health SolutionsMergers & AcquisitionsNuPathePharmaceuticalTeva Pharmaceutical Industries

Forest Labs to spend $2.9 billion on acquiring Aptalis

Forest Labs to spend $2.9 billion on acquiring Aptalis

09-01-2014

Confirming recent speculative reports, US drugmaker Forest Laboratories says it has entered into a definitive…

AptalisForest LaboratoriesGastro-intestinalsMergers & AcquisitionsPharmaceuticalRare diseases

Eddingpharm acquires global rights to oncology assets, including telatinib, from ACT Biotech

08-01-2014

Chinese drug firm Eddingpharm has entered into an asset purchase agreement (APA) with a private, venture…

ACT BiotechEddingpharmMergers & AcquisitionsOncologyPharmaceuticaltelatinib

Probiodrug sells its CDK9 inhibitor program to AstraZeneca

Probiodrug sells its CDK9 inhibitor program to AstraZeneca

06-01-2014

Privately-held German company Probiodrug says it has transferred its experimental cyclin-dependent kinase…

AstraZenecaInflammatory diseasesMergers & AcquisitionsOncologyPharmaceuticalProbiodrug

NeXeption forms new company, Alexar Therapeutics, to develop novel LXR agonist portfolio

03-01-2014

US biopharma management company NeXeption says it has secured $21.5 million in Series A financing to…

A-110Alexar TherapeuticsDermatologicalsFinancialMergers & AcquisitionsNeXeptionPharmaceuticalResearch

Ikaria sells commercial business to Madison Dearborn for $1.6 billion

03-01-2014

US critical care company Ikaria says that its investor group and employee shareholders have reached a…

IkariaInomaxMergers & AcquisitionsPharmaceuticalRespiratory and Pulmonary

226 to 250 of 641 results

COMPANY SPOTLIGHT

Menarini

Back to top